Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.
Thornton V, Lennon D, Rasanathan K, O'Hallahan J, Oster P, Stewart J, Tilman S, Aaberge I, Feiring B, Nokleby H, Rosenqvist E, White K, Reid S, Mulholland K, Wakefield MJ, Martin D.
Thornton V, et al.
Vaccine. 2006 Feb 27;24(9):1395-400. doi: 10.1016/j.vaccine.2005.09.043. Epub 2005 Oct 4.
Vaccine. 2006.
PMID: 16242221
Clinical Trial.